Artículos

Neuroleptic induced catatonia clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome / Joseph Lee en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 3-10 Título : Neuroleptic induced catatonia clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome Tipo de documento: texto impreso Autores: Joseph Lee, Autor Fecha de publicación: 2022 Artículo en la página: pp. 3-10 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Catatonia, Catatonia inducida por neurolépticos, Síndrome neuroléptico maligno, Reacciones extrapiramidales, Benzodiazepinas Resumen: Neuroleptic-induced catatonia (NIC), manifested in an extrapyramidal-catatonic syndrome, has been sporadically reported in the literature. Confusion surrounds its relationship to neuroleptic malignant syndrome (NMS) and extrapyramidal reactions to neuroleptics. Link: ./index.php?lvl=notice_display&id=29464 [artículo] Neuroleptic induced catatonia clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome [texto impreso] / Joseph Lee, Autor . - 2022 . - pp. 3-10. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 3-10 Palabras clave: Catatonia, Catatonia inducida por neurolépticos, Síndrome neuroléptico maligno, Reacciones extrapiramidales, Benzodiazepinas Resumen: Neuroleptic-induced catatonia (NIC), manifested in an extrapyramidal-catatonic syndrome, has been sporadically reported in the literature. Confusion surrounds its relationship to neuroleptic malignant syndrome (NMS) and extrapyramidal reactions to neuroleptics. Link: ./index.php?lvl=notice_display&id=29464

Effects of the serotonin 1a, 2a, 2c, 3a, and 3b and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome / Yusuke Murata en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 11-17 Título : Effects of the serotonin 1a, 2a, 2c, 3a, and 3b and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome Tipo de documento: texto impreso Autores: Yusuke Murata, Autor ; Daisuke Kobayashi, Autor ; Nanae Imuta, Autor Fecha de publicación: 2022 Artículo en la página: pp. 11-17 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Síndrome de discontinuación, Paroxetina, Receptor de serotonina 1A, Polimorfismos genéticos Resumen: Paroxetine discontinuation symptoms can at times be severe enough to reduce the quality of life. However, it is currently not possible to predict the occurrence of discontinuation syndrome before the initiation or discontinuation of paroxetine treatment. Link: ./index.php?lvl=notice_display&id=29465 [artículo] Effects of the serotonin 1a, 2a, 2c, 3a, and 3b and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome [texto impreso] / Yusuke Murata, Autor ; Daisuke Kobayashi, Autor ; Nanae Imuta, Autor . - 2022 . - pp. 11-17. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 11-17 Palabras clave: Síndrome de discontinuación, Paroxetina, Receptor de serotonina 1A, Polimorfismos genéticos Resumen: Paroxetine discontinuation symptoms can at times be severe enough to reduce the quality of life. However, it is currently not possible to predict the occurrence of discontinuation syndrome before the initiation or discontinuation of paroxetine treatment. Link: ./index.php?lvl=notice_display&id=29465

Desvenlafaxine for the prevention of relapse in major depressive disorder / Karl Rickels en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 18-24 Título : Desvenlafaxine for the prevention of relapse in major depressive disorder : Results of a randomized trial Tipo de documento: texto impreso Autores: Karl Rickels, Autor ; Stuart A. Montgomery, Autor ; Karen A. Tourian, Autor Fecha de publicación: 2022 Artículo en la página: pp. 18-24 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Desvenlafaxina, Eventos adversos, Trastorno depresivo mayor Resumen: To compare the efficacy and safety of desvenlafaxine (administered as desvenlafaxine succinate) with placebo in reducing relapse rate in patients with major depressive disorder (MDD). Link: ./index.php?lvl=notice_display&id=29466 [artículo] Desvenlafaxine for the prevention of relapse in major depressive disorder : Results of a randomized trial [texto impreso] / Karl Rickels, Autor ; Stuart A. Montgomery, Autor ; Karen A. Tourian, Autor . - 2022 . - pp. 18-24. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 18-24 Palabras clave: Desvenlafaxina, Eventos adversos, Trastorno depresivo mayor Resumen: To compare the efficacy and safety of desvenlafaxine (administered as desvenlafaxine succinate) with placebo in reducing relapse rate in patients with major depressive disorder (MDD). Link: ./index.php?lvl=notice_display&id=29466

Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone / Megan J. Shram en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 25-33 Título : Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone Tipo de documento: texto impreso Autores: Megan J. Shram, Autor ; Gayatri Sathyan, Autor ; Sarita Khanna, Autor Fecha de publicación: 2022 Artículo en la página: pp. 25-33 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Hidromorfona, Potencial de abuso, Liberación prolongada, Test - retest Resumen: Immediate release (IR) hydromorphone has experienced significant misuse and abuse. An extended release (ER) hydromorphone formulation has been developed to provide sustained pain relief and may reduce the likelihood for abuse by delaying absorption. In this double-blind, placebo-controlled, randomized, 2-part crossover study, the abuse potential of single oral doses of hydromorphone ER (intact: 16-, 32-, and 64-mg; milled: 8-mg) was compared with 8-mg hydromorphone IR and placebo. Link: ./index.php?lvl=notice_display&id=29467 [artículo] Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone [texto impreso] / Megan J. Shram, Autor ; Gayatri Sathyan, Autor ; Sarita Khanna, Autor . - 2022 . - pp. 25-33. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 25-33 Palabras clave: Hidromorfona, Potencial de abuso, Liberación prolongada, Test - retest Resumen: Immediate release (IR) hydromorphone has experienced significant misuse and abuse. An extended release (ER) hydromorphone formulation has been developed to provide sustained pain relief and may reduce the likelihood for abuse by delaying absorption. In this double-blind, placebo-controlled, randomized, 2-part crossover study, the abuse potential of single oral doses of hydromorphone ER (intact: 16-, 32-, and 64-mg; milled: 8-mg) was compared with 8-mg hydromorphone IR and placebo. Link: ./index.php?lvl=notice_display&id=29467

A single blinded case control study of memantine in severe obsessive compulsive disorder / S. Evelyn Stewart en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 34-39 Título : A single blinded case control study of memantine in severe obsessive compulsive disorder Tipo de documento: texto impreso Autores: S. Evelyn Stewart, Autor ; Eric A. Jenike, Autor ; Dianne M. Hezel, Autor Fecha de publicación: 2022 Artículo en la página: pp. 34-39 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno obsesivo - compulsivo (TOC), Memantina, Glutamato, Agentes potenciadores, Trastornos de ansiedad, Tratamiento Resumen: Obsessive-compulsive disorder (OCD) is a common debilitating psychiatric illness that typically improves but does not remit with first-line medication and behavioral treatments. Serotonergic agents including selective serotonin reuptake inhibitors and clomipramine have provided the mainstay of OCD medication management for decades. Link: ./index.php?lvl=notice_display&id=29468 [artículo] A single blinded case control study of memantine in severe obsessive compulsive disorder [texto impreso] / S. Evelyn Stewart, Autor ; Eric A. Jenike, Autor ; Dianne M. Hezel, Autor . - 2022 . - pp. 34-39. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 34-39 Palabras clave: Trastorno obsesivo - compulsivo (TOC), Memantina, Glutamato, Agentes potenciadores, Trastornos de ansiedad, Tratamiento Resumen: Obsessive-compulsive disorder (OCD) is a common debilitating psychiatric illness that typically improves but does not remit with first-line medication and behavioral treatments. Serotonergic agents including selective serotonin reuptake inhibitors and clomipramine have provided the mainstay of OCD medication management for decades. Link: ./index.php?lvl=notice_display&id=29468

Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with alzheimer disease / Arash Mowla en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 40-43 Título : Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with alzheimer disease : A double blind, randomized clinical trial Tipo de documento: texto impreso Autores: Arash Mowla, Autor ; Azadeh Pani, Autor Fecha de publicación: 2022 Artículo en la página: pp. 40-43 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alzheimer, Alteración del comportamiento, Topiramato Resumen: Behavioral disturbances are determining factors in handling patients with Alzheimer dementia. The current pharmacotherapy for behavioral symptoms associated with dementia is not satisfactory. Our goal was to compare a new anticonvulsant, topiramate, with a usually used medication, risperidone, for controlling behavioral disturbances of patients with Alzheimer dementia. Link: ./index.php?lvl=notice_display&id=29469 [artículo] Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with alzheimer disease : A double blind, randomized clinical trial [texto impreso] / Arash Mowla, Autor ; Azadeh Pani, Autor . - 2022 . - pp. 40-43. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 40-43 Palabras clave: Alzheimer, Alteración del comportamiento, Topiramato Resumen: Behavioral disturbances are determining factors in handling patients with Alzheimer dementia. The current pharmacotherapy for behavioral symptoms associated with dementia is not satisfactory. Our goal was to compare a new anticonvulsant, topiramate, with a usually used medication, risperidone, for controlling behavioral disturbances of patients with Alzheimer dementia. Link: ./index.php?lvl=notice_display&id=29469

Olanzapine versus haloperidol in the management of borderline personality disorder / Saeed Shoja Shafti en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 44-47 Título : Olanzapine versus haloperidol in the management of borderline personality disorder : A randomized double blind trial Tipo de documento: texto impreso Autores: Saeed Shoja Shafti, Autor ; Bahman Shahveisi, Autor Fecha de publicación: 2022 Artículo en la página: pp. 44-47 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Olanzapina, Haloperidol, Trastorno límite de la personalidad Resumen: The newer atypical antipsychotics seem to be as effective as previous antipsychotics for impulsivity and aggressiveness of patients with borderline personality disorder (BPD). Objective of this assessment was to compare the effectiveness of olanzapine versus haloperidol in BPD. Link: ./index.php?lvl=notice_display&id=29470 [artículo] Olanzapine versus haloperidol in the management of borderline personality disorder : A randomized double blind trial [texto impreso] / Saeed Shoja Shafti, Autor ; Bahman Shahveisi, Autor . - 2022 . - pp. 44-47. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 44-47 Palabras clave: Olanzapina, Haloperidol, Trastorno límite de la personalidad Resumen: The newer atypical antipsychotics seem to be as effective as previous antipsychotics for impulsivity and aggressiveness of patients with borderline personality disorder (BPD). Objective of this assessment was to compare the effectiveness of olanzapine versus haloperidol in BPD. Link: ./index.php?lvl=notice_display&id=29470

Exploratory randomized clinical study of pagoclone in persistent developmental stuttering / Gerald Maguire en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 48-56 Título : Exploratory randomized clinical study of pagoclone in persistent developmental stuttering : The examining pagoclone for persistent developmental stuttering study Tipo de documento: texto impreso Autores: Gerald Maguire, Autor ; David Franklin, Autor ; Nick G. Vatakis, Autor Fecha de publicación: 2022 Artículo en la página: pp. 48-56 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Pagoclone, Tartamudeo, Porcentaje de sílabas tartamudeadas, Ensayo clínico Resumen: Stuttering is a speech disorder in which the flow of speech is disrupted by repetitions, prolongation, and blocks of sounds, syllables, or words. No pharmacological treatments are approved for use in stuttering, and the most common form of treatment is speech therapy. Link: ./index.php?lvl=notice_display&id=29471 [artículo] Exploratory randomized clinical study of pagoclone in persistent developmental stuttering : The examining pagoclone for persistent developmental stuttering study [texto impreso] / Gerald Maguire, Autor ; David Franklin, Autor ; Nick G. Vatakis, Autor . - 2022 . - pp. 48-56. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 48-56 Palabras clave: Pagoclone, Tartamudeo, Porcentaje de sílabas tartamudeadas, Ensayo clínico Resumen: Stuttering is a speech disorder in which the flow of speech is disrupted by repetitions, prolongation, and blocks of sounds, syllables, or words. No pharmacological treatments are approved for use in stuttering, and the most common form of treatment is speech therapy. Link: ./index.php?lvl=notice_display&id=29471

Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research / Wilma Knoll en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 57-63 Título : Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research Tipo de documento: texto impreso Autores: Wilma Knoll, Autor ; Carolina J.P.W. Keijsers, Autor ; Paul A.F. Jansen, Autor Fecha de publicación: 2022 Artículo en la página: pp. 57-63 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Escalas de calificación, Parkinsonismo inducido por fármacos, Revisión sistemática Resumen: Drug-induced parkinsonism (DIP) is one of the most common adverse effects of antipsychotic agents. The limited agreement about which rating scale should be used in clinical practice to assess DIP prompted us to review the feasibility and the psychometric qualities of the available instruments. Link: ./index.php?lvl=notice_display&id=29472 [artículo] Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research [texto impreso] / Wilma Knoll, Autor ; Carolina J.P.W. Keijsers, Autor ; Paul A.F. Jansen, Autor . - 2022 . - pp. 57-63. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 57-63 Palabras clave: Escalas de calificación, Parkinsonismo inducido por fármacos, Revisión sistemática Resumen: Drug-induced parkinsonism (DIP) is one of the most common adverse effects of antipsychotic agents. The limited agreement about which rating scale should be used in clinical practice to assess DIP prompted us to review the feasibility and the psychometric qualities of the available instruments. Link: ./index.php?lvl=notice_display&id=29472